P14 ARF promoter region methylation as a marker for gliomas diagnosis

Medical Oncology

Volumn 28, Issue 4, 2011, Pages 1218-1224

  He, Jie ^a   Qiao, Jian Bing ^b   Zhu, Haiqing ^c  

^a Soochow University   (China)

^b NANJING CHEST HOSPITAL   (China)

^c THE AFFILIATED BRAIN HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Glioma; Immunohistochemistry; Methylation; p14 ARF; P53

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; GENOMIC DNA; MUTANT PROTEIN; PROTEIN P53; TUMOR MARKER;

ADOLESCENT; ADULT; AGED; ARTICLE; ASTROCYTOMA; AUTOPSY; CANCER SURVIVAL; CHILD; CONTROLLED STUDY; CPG ISLAND; DIAGNOSTIC VALUE; DNA METHYLATION; FEMALE; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; PROGRESSION FREE SURVIVAL; PROMOTER REGION; PROTEIN EXPRESSION; SCHOOL CHILD; TUMOR DIAGNOSIS; BIOSYNTHESIS; BRAIN TUMOR; CANCER GRADING; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; NUCLEOTIDE SEQUENCE;

ADOLESCENT; ADULT; AGED; BASE SEQUENCE; BRAIN NEOPLASMS; CHILD; DNA METHYLATION; FEMALE; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM GRADING; POLYMERASE CHAIN REACTION; PROGNOSIS; PROMOTER REGIONS, GENETIC; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P14ARF; TUMOR SUPPRESSOR PROTEIN P53; YOUNG ADULT;

EID: 84655165034     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-010-9651-8     Document Type: Article

References (34)

1. S Loew U Schmidt A Unterberg ME Halatsch 2009 The epidermal growth factor receptor as a therapeutic target in glioblastoma multiforme and other malignant neoplasms Anticancer Agents Med Chem. 9 703 715
2. A Ayuso-Sacido JA Moliterno S Kratovac GS Kapoor DM O'Rourke EC Holland JM García-Verdugo NS Roy JA Boockvar 2010 Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells J Neurooncol 97 323 37
3. T Homma T Fukushima S Vaccarella Y Yonekawa PL Di Patre S Franceschi H Ohgaki 2006 Correlation among pathology, genotype, and patient outcomes in glioblastoma J Neuropathol Exp Neurol 65 846 854
4. H Ohgaki H Ohgaki P Dessen B Jourde S Horstmann T Nishikawa PL Di Patre C Burkhard D Schüler NM Probst-Hensch PC Maiorka N Baeza P Pisani Y Yonekawa MG Yasargil UM Lütolf P Kleihues 2004 Genetic pathways to glioblastoma: a population-based study Cancer Res 64 6892 6899
5. H Ohgaki 2005 Genetic pathways to glioblastomas Neuropathology. 25 1 7
6. NF Marko RA Prayson GH Barnett RJ Weil 2010 Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study Genomics. 95 16 24
7. YK Jeon K Park CK Park SH Paek HW Jung SH Park 2007 Chromosome 1p and 19q status and p53 and p16 expression patterns as prognostic indicators of oligodendroglial tumors: a clinicopathological study using fluorescence in situ hybridization Neuropathology. 27 10 20
8. K Aldape PC Burger A Perry 2007 Clinicopathologic aspects of 1p/19q loss and the diagnosis of oligodendroglioma Arch Pathol Lab Med 131 242 251
9. D Fontaine F Vandenbos C Lebrun V Paquis M Frenay 2008 Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice Rev Neurol (Paris). 164 595 604
10. A Elias MD Siegelin A Steinmüller A von Deimling U Lass B Korn W Mueller 2009 Epigenetic silencing of death receptor 4 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in gliomas Clin Cancer Res 15 5457 5465
11. RP Nagarajan JF Costello 2009 Molecular epigenetics and genetics in neuro-oncology Neurotherapeutics. 6 436 446
12. L Chin J Pomerantz RA DePinho 1998 The INK4a/ARF tumor suppressor: one gene-two products-two pathways Trends Biochem Sci 23 291 296
13. T Watanabe Y Katayama A Yoshino K Yachi T Ohta A Ogino C Komine T Fukushima 2007 Aberrant hypermethylation of p14ARF and O6-methylguanine-DNA methyltransferase genes in astrocytoma progression Brain Pathol 17 5 10
14. J Carr E Bell AD Pearson UR Kees H Beris J Lunec DA Tweddle 2006 Increased frequency of aberrations in the p53/MDM2/p14(ARF) pathway in neuroblastoma cell lines established at relapse Cancer Res 66 2138 2145
15. CL Brooks W Gu 2004 Dynamics in the p53-Mdm2 ubiquitination pathway Cell Cycle. 3 895 899
16. S Ohta H Uemura Y Matsui H Ishiguro K Fujinami K Kondo H Miyamoto T Yazawa K Danenberg PV Danenberg I Tohnai Y Kubota 2009 Alterations of p16 and p14ARF genes and their 9p21 locus in oral squamous cell carcinoma Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 81 91
17. M Kim SH Yim NS Cho SH Kang DH Ko B Oh TY Kim HJ Min CJ She HJ Kang HY Shin HS Ahn SS Yoon BK Kim HR Shin KS Han HI Cho DS Lee 2009 Homozygous deletion of CDKN2A (p16, p14) and CDKN2B (p15) genes is a poor prognostic factor in adult but not in childhood B-lineage acute lymphoblastic leukemia: a comparative deletion and hypermethylation study Cancer Genet Cytogenet 195 59 65
18. K Kominami T Nagasaka HM Cullings N Hoshizima H Sasamoto J Young BA Leggett N Tanaka N Matsubara 2009 Methylation in p14(ARF) is frequently observed in colorectal cancer with low-level microsatellite instability J Int Med Res 37 1038 1045
19. J Xiong RJ Epstein 2009 Growth inhibition of human cancer cells by 5-aza-2′-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status Mol Cancer Ther 8 779 785
20. P Gonzlaez-Gomez MJ Bello D Arjona J Lomas ME Alonso JM De Campos J Vaquero A Isla M Gutierrez JA Rey 2003 Promoter hypermethylation of multiple genes in astrocytic gliomas Int J Oncology. 22 601 608
21. J Yu H Zhang J Gu S Lin J Li W Lu Y Wang J Zhu 2004 Methylation profiles of thirty-four promoter-CpG islands and concordant methylation behaviours of sixteen genes that may contribute to carcinogenesis of astrocytoma BMC Cancer. 4 65 79
22. K Nosho T Kawasaki AT Chan M Ohnishi Y Suemoto GJ Kirkner CS Fuchs S Ogino 2008 Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype Histopathology 53 588 598
23. F Ksiaa S Ziadi K Amara S Korbi M Trimeche 2009 Biological significance of promoter hypermethylation of tumor-related genes in patients with gastric carcinoma Clin Chim Acta. 404 128 133
24. WK De Jong GF Verpooten H Kramer J Louwagie HJ Groen 2009 Promoter methylation primarily occurs in tumor cells of patients with non-small cell lung cancer Anticancer Res 29 363 369
25. Lin HH, Ke HL, Huang SP, Wu WJ, Chen YK, Chang LL. Increase sensitivity in detecting superficial, low grade bladder cancer by combination analysis of hypermethylation of E-cadherin, p16, p14, RASSF1A genes in urine. Urol Oncol. 2009. doi: 10.1016/j.urolonc.2008.12.008.
26. LT Kuo KT Kuo MJ Lee CC Wei F Scaravilli JC Tsai HM Tseng MF Kuo YK Tu 2009 Correlation among pathology, genetic and epigenetic profiles, and clinical outcome in oligodendroglial tumors Int J Cancer 124 2872 2879
27. MC Santos CP Saito SR Line 2008 Extraction of genomic DNA from paraffin-embedded tissue section of human fetuses fixed and stored in formalin for long periods Pathol Res Pract 204 633 636
28. M Sato Y Horio Y Sekido JD Minna K Shimokata Y Hasegawa 2002 The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines Oncogene. 21 4822 4829
29. R Hamelin P Laurent-Puig S Olschwang N Jego B Asselain Y Remvikos J Girodet RJ Salmon G Thomas 1994 Association of p53 mutations with short survival in colorectal cancer Gastroenterology 106 42 48
30. G Winchester 1983 p53 protein and control of growth Nature. 303 660 661
31. M Oren 1985 The p53 cellular tumor antigen: gene structure, expression and protein properties Biochim Biophys Acta 823 67 78
32. DP Lane S Benchimol 1990 p53: oncogene or anti-oncogene? Genes Dev 4 1 8
33. I Kondo S Iida Y Takagi K Sugihara 2008 MDM2 mRNA expression in the p53 pathway may predict the potential of invasion and liver metastasis in colorectal cancer Dis Colon Rectum. 51 1395 1402
34. A Pacifico LH Goldberg K Peris S Chimenti G Leone HN Ananthaswamy 2008 Loss of CDKN2A and p14ARF expression occurs frequently in human monmelanoma skin cancers Br J Dermatol 158 291 297